Eagle's Eye View: Your Weekly CV Update From ACC.org (Week of March 4)

This week's View lists key points to remember about the American Heart Association 2019 update on the statistics regarding heart disease, stroke, and cardiovascular risk factors and discusses two clinical trials evaluating anticoagulants compared with placebo among patients with cancer and risk for venous thromboembolism.

Subscribe on iTunes | Subscribe on Google Play

Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Cardiac Surgery, Cardio-Oncology, Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Prevention, Pulmonary Hypertension and Venous Thromboembolism, Anticoagulation Management and Atrial Fibrillation, Anticoagulation Management and Venothromboembolism, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Aortic Surgery, Cardiac Surgery and Arrhythmias, Cardiac Surgery and Heart Failure, Lipid Metabolism, Nonstatins, Acute Heart Failure, Heart Transplant, Interventions and Imaging, Interventions and Vascular Medicine, Angiography, Nuclear Imaging, Hypertension

Keywords: EaglesEyeView, American Heart Association, Anticoagulants, Atrial Fibrillation, Cardiac Catheterization, Cardiotoxicity, Cardiovascular Diseases, Coronary Artery Bypass, Coronary Disease, Cholesterol, LDL, Defibrillators, Implantable, Emergency Medical Services, Endocarditis, Heart Transplantation, Heart Failure, Hypertension, Hemorrhage, Lung Transplantation, Lymphoma, Neoplasms, Inpatients, Myocardial Infarction, Oximetry, Pacemaker, Artificial, Percutaneous Coronary Intervention, Primary Prevention, Pulmonary Embolism, Pyridones, Pyrazoles, Risk, Risk Factors, Stroke, Stroke Volume, Tachycardia, Ventricular, Vascular Diseases, Venous Thromboembolism, Venous Thrombosis, Ventricular Fibrillation, Arrhythmias, Cardiac, Dyslipidemias, Coronary Angiography


< Back to Listings